Skip to content

OOSTERAPOTHEEK: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

OOSTERAPOTHEEK

BE 0890.133.267
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€36,265
2024 · €22,170+€14,095
Equity
€194,406
2024 · €169,964+€24,442
Cash
€108,705
2024 · €72,466+€36,239
Balance sheet total
€275,743
2024 · €234,489+€41,255

Largest movements

2024 to 2025
Assets
  • Cash +€36,239

    up €36,239 (+50.0%), from €72,466 to €108,705

    mainly Net result for the year (+€36,265) and Depreciation (+€13,331)

  • Receivables within one year +€12,724

    up €12,724 (+34.0%), from €37,435 to €50,160

    of which Trade receivables: +€14,619

  • Tangible fixed assets -€9,892

    down €9,892 (-21.4%), from €46,261 to €36,370

    of which Plant, machinery and equipment: -€7,565

  • Stocks and contracts +€9,219

    up €9,219 (+15.3%), from €60,076 to €69,295

  • Deferred charges and accrued income -€6,038

    down €6,038 (-61.9%), from €9,750 to €3,712

Equity and liabilities
  • Reserves +€24,442

    up €24,442 (+24.0%), from €101,740 to €126,183

  • Trade debts +€13,070

    up €13,070 (+68.7%), from €19,037 to €32,106

  • Other debts +€10,182

    up €10,182 (+33.5%), from €30,363 to €40,545

  • Accrued charges and deferred income -€8,017

    down €8,017 (-87.6%), from €9,152 to €1,135

Income statement
  • Gross operating margin +€25,221

    up €25,221 (+36.2%), from €69,703 to €94,924

  • Taxes +€4,685

    up €4,685 (+49.8%), from €9,415 to €14,100

  • Staff costs +€4,175

    up €4,175 (+19.1%), from €21,913 to €26,088

  • Depreciation +€1,442

    up €1,442 (+12.1%), from €11,889 to €13,331

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €22,170
Gross operating margin +€25,221
Staff costs -€4,175
Depreciation -€1,442
Other operating charges -€80
Other operating items -€43
Financial income -€212
Financial charges -€489
Taxes -€4,685
Result 2025 €36,265
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€50,504
Investment -€2,441
Financing -€11,823
Cash 2024 €72,466
Net result for the year +€36,265
Depreciation +€13,331
Stocks and contracts -€9,219
Receivables within one year -€12,724
Deferred charges and accrued income +€6,038
Trade debts +€13,070
Tax, wage and social debts +€1,578
Other debts +€10,182
Accrued charges and deferred income -€8,017
Investment in fixed assets (net) -€3,440
Current investments +€998
Contributions, distributions and other -€11,823
Cash 2025 €108,705
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €234,489 €275,743 +€41,255 +17.6%
Fixed assets 21/28 €48,761 €38,870 -€9,892 -20.3%
Tangible fixed assets 22/27 €46,261 €36,370 -€9,892 -21.4%
Land and buildings 22 €21,777 €16,984 -€4,794 -22.0%
Plant, machinery and equipment 23 €23,790 €16,225 -€7,565 -31.8%
Furniture and vehicles 24 €694 €3,161 +€2,467 +356%
Financial fixed assets 28 €2,500 €2,500 = 0.0%
Current assets 29/58 €185,727 €236,874 +€51,146 +27.5%
Stocks and contracts in progress 3 €60,076 €69,295 +€9,219 +15.3%
Stocks 30/36 €60,076 €69,295 +€9,219 +15.3%
Amounts receivable within one year 40/41 €37,435 €50,160 +€12,724 +34.0%
Trade receivables 40 €34,914 €49,534 +€14,619 +41.9%
Other amounts receivable 41 €2,521 €626 -€1,895 -75.2%
Current investments 50/53 €6,000 €5,002 -€998 -16.6%
Cash at bank and in hand 54/58 €72,466 €108,705 +€36,239 +50.0%
Deferred charges and accrued income 490/1 €9,750 €3,712 -€6,038 -61.9%
Total equity and liabilities 10/49 €234,489 €275,743 +€41,255 +17.6%
Equity 10/15 €169,964 €194,406 +€24,442 +14.4%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €101,740 €126,183 +€24,442 +24.0%
Distributable reserves 133 €101,740 €126,183 +€24,442 +24.0%
Profit (loss) carried forward 14 €49,623 €49,623 = 0.0%
Amounts payable 17/49 €64,525 €81,337 +€16,812 +26.1%
Amounts payable within one year 42/48 €55,373 €80,202 +€24,829 +44.8%
Trade debts 44 €19,037 €32,106 +€13,070 +68.7%
Suppliers 440/4 €19,037 €32,106 +€13,070 +68.7%
Taxes, remuneration and social security 45 €5,973 €7,551 +€1,578 +26.4%
Taxes 450/3 €3,011 €3,582 +€572 +19.0%
Remuneration and social security 454/9 €2,963 €3,969 +€1,006 +34.0%
Other amounts payable 47/48 €30,363 €40,545 +€10,182 +33.5%
Accrued charges and deferred income 492/3 €9,152 €1,135 -€8,017 -87.6%
Remuneration, social security and pensions 62 €21,913 €26,088 +€4,175 +19.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €11,889 €13,331 +€1,442 +12.1%
Other operating charges 640/8 €705 €785 +€80 +11.4%
Non-recurring operating charges 66A - €43 +€43
Gross operating margin 9900 €69,703 €94,924 +€25,221 +36.2%
Operating profit (loss) 9901 €35,195 €54,676 +€19,481 +55.4%
Financial income 75/76B €756 €545 -€212 -28.0%
Recurring financial income 75 €756 €545 -€212 -28.0%
Financial charges 65/66B €4,366 €4,855 +€489 +11.2%
Recurring financial charges 65 €4,366 €4,855 +€489 +11.2%
Profit (loss) for the period before taxes 9903 €31,585 €50,366 +€18,781 +59.5%
Income taxes 67/77 €9,415 €14,100 +€4,685 +49.8%
Profit (loss) for the period 9904 €22,170 €36,265 +€14,095 +63.6%
Profit (loss) for the period to be appropriated 9905 €22,170 €36,265 +€14,095 +63.6%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.